15158 - ISTH "Thrombocytopenia"

Through its educational arm, the ISTH Academy, the International Society on Thrombosis and Haemostasis (ISTH) has begun hosting a series of webinars on practical thrombosis and haemostasis issues that scientists and physicians frequently confront. These webinars will allot time for participants to ask questions and will cover the latest information on relevant topics.

Moderated by: Chris Ward

Inherited Platelet Disorders – Marco Cattaneo

Inherited Platelet Disorders (IPD) include Inherited Thrombocytopenias (IT) and Inherited Platelet Function Disorders (IPFD). IT are more common than generally believed and should not be confused with acquired thrombocytopenias, in order to avoid futile and potentially dangerous treatments. The bleeding manifestations of IT are very rarely severe. Some IT are associated with inherited defects in other organs or systems (syndromic IT). Inherited Platelet Function Disorders (IPFD) are also more common than generally believed. They may be associated with normal or decreased platelet cont. While clinicians should be aware of the main characteristics of IPD in order to raise the diagnostic suspicion, the definite diagnosis should be demanded to specialized laboratories, implementing complex diagnostic workups. The presentation will include a practical approach to the differential diagnosis of IT with acquired thrombocytopenias, the diagnostic workup management of IPFD. 

Genetic basis of congenital macrothrombocytopenia – Shinji Kunishima

Recent progress in the elucidation of underlying defects and the developments of diagnostic tests has renewed our understanding of congenital macrothrombocytopenia. The condition is not rare as previously thought. This presentation will address the genetic and molecular basis of congenital macrothrombocytopenia. The presentation includes a practical approach to the differential diagnosis and description of recently identified forms.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
Designation of Credit Statement:
The Medical College of Wisconsin designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Please note: The course fee is $25.00 in addition to a $2.50 processing fee which is assessed for all electronic registrations.
 
More information and online registration:  http://www.prolibraries.com/isth/
 
 
Sponsored by an unrestricted educational grant from Instrumentation Laboratory 
 

Target Audience

  • Clinicians and laboratory personnel interested in the diagnosis and management of patients with bleeding diathese
  • Researchers
  • Nurses
  • Allied Health Professionals

Learning Objectives

At the conclusion of this activity, I will be able to:

  • Better understand the knowledge and diagnosis process of congenital macrothrombocytopenia
  • Analyze and understand the existence of IPD and will acquired some information on their diagnostic workups and clinical management.
Additional information

CME Coordinator Contact Information

Name: 
Cary Clark
Phone Number: 
+1 (919) 929-3807
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
03/25/2015
Course expires: 
03/25/2016
Cost:
$2.50
Planning Committee:
Yukio Ozaki
Geoff Barnes
Chris Ward
Cary Clark
Stephen Watson
 

Moderated by: Chris Ward

Inherited Platelet Disorders – Marco Cattaneo

Inherited Platelet Disorders (IPD) include Inherited Thrombocytopenias (IT) and Inherited Platelet Function Disorders (IPFD). IT are more common than generally believed and should not be confused with acquired thrombocytopenias, in order to avoid futile and potentially dangerous treatments. The bleeding manifestations of IT are very rarely severe. Some IT are associated with inherited defects in other organs or systems (syndromic IT). Inherited Platelet Function Disorders (IPFD) are also more common than generally believed. They may be associated with normal or decreased platelet cont. While clinicians should be aware of the main characteristics of IPD in order to raise the diagnostic suspicion, the definite diagnosis should be demanded to specialized laboratories, implementing complex diagnostic workups. The presentation will include a practical approach to the differential diagnosis of IT with acquired thrombocytopenias, the diagnostic workup management of IPFD. 

Genetic basis of congenital macrothrombocytopenia – Shinji Kunishima

Recent progress in the elucidation of underlying defects and the developments of diagnostic tests has renewed our understanding of congenital macrothrombocytopenia. The condition is not rare as previously thought. This presentation will address the genetic and molecular basis of congenital macrothrombocytopenia. The presentation includes a practical approach to the differential diagnosis and description of recently identified forms.

 
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  

Name

Company

Role

Chris Ward, MD

Bayer

Advisory Board, Speaker

 

Pfizer-BMS

Advisory Board, Speaker

Boehringer-Ingelheim

Advisory Board, Speaker

Alexion

Advisory Board

Medimark

Steering Committee Member, Speaker

Marco Cattaneo, MD

Astra Zeneca

Advisory Board, Speaker

 

Eli Lilly

Advisory Board, Speaker

Daiichi Sankyo

Advisory Board, Speaker

Geoff Barnes

BMS, Pfizer, Blue Cross Blue Shield of Michigan

Primary Investigator & Co-Investigator

Yukio Ozaki

Sysmex

Advisory Board

  
In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
03/25/2015
Course expires: 
03/25/2016

Price

Cost:
$2.50
Please login or register to take this course.

Required Hardware/software

To view the webcast on your computer go to https://www.isth.org/  click the Events/Webinars tab and view the ISTH 2015 Archived Webinars

Participant Privacy